Medexus Pharmaceuticals Inc. endeavors to share all the information that our investors require in order to make informed investment decisions. For questions regarding our business operations, partnerships, our product pipeline/portfolio, or for general inquiries, please reach out us using the form provided.
Medexus Pharmaceuticals, Inc.
1 Place du Commerce
Suite 225
Verdun, QC H3E 1A2
Canada
Ken d’Entremont
Chief Executive Officer and Director
ken.dentremont@medexus.com
905-676-0800
Roland Boivin
Chief Financial Officer
roland.boivin@medexus.com
514-344-8765
Crescendo Communications, LLC
David Waldman / Natalya Rudman
mdp@crescendo-ir.com
212-671-1020
Tina Byers
Adelaide Capital
Tel: 905-330-3275
E-mail: tina@adcap.ca
Direct Financial Strategies and Communication Inc.
Frank Candido
frank.candido@medexus.com
514-969-5530
USA: For adverse events, medical inquiries, and product-related concerns, please call 1-855-336-3322.
Canada: For adverse events, medical inquiries, and product-related concerns, please call 1-877-633-3987 or by written at MedexusPV@innomar-strategies.com.